← Eichor
Condition: Moderate Renal Impairment Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Moderate Renal Impairment

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Clofutriben Pharmacokinetics in Patients With Impaired Renal Function
Phase 1 · 1 location(s) · Sparrow Pharmaceuticals · NCT07227922Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hype
Phase 3 · 40 location(s) · University Hospital, Tours · NCT05732727Does Urinary TIMP2 and IGFBP7 Can Identify High Risk Patients of Progression From Mild and Moderate to Severe Acute Kidn
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT03547414Colchicine in Chronic Kidney Disease Patients
Phase 3 · 1 location(s) · Hospital General Universitario Gregorio Marañon · NCT06998862A Pharmacokinetics and Safety Study of Azvudine Tablets in Subjects With Mild-To-Moderate GFR Decline in Renal Insuffici
Phase 1 · 1 location(s) · Henan Genuine Biotech Co., Ltd. · NCT07001436CAR T-cell Therapy in Patients With Renal Dysfunction
Phase 2 · 1 location(s) · Northside Hospital, Inc. · NCT05909059A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function
Phase 1 · 1 location(s) · Shandong Suncadia Medicine Co., Ltd. · NCT07322016A Phase I Clinical Trial to Evaluate the Pharmacokinetic Characteristics of Ammoxetine Hydrochloride Enteric-Coated Tabl
Phase 1 · 1 location(s) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · NCT07694869Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Phase 3 · 19 location(s) · Alessandro Doria · NCT06217302Nephroprotective Measures in Critically Ill Patients With Moderate/Severe Acute Kidney Injury
Phase N/A · 3 location(s) · Universität Münster · NCT06472999Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Dise
Phase 4 · 1 location(s) · Centenario Hospital Miguel Hidalgo · NCT07405216Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
Phase 2 · 16 location(s) · Vifor Fresenius Medical Care Renal Pharma · NCT06593392Probiotic Supplementation and Disease Progression in CKD: A Randomized Trial
Phase 1/Phase 2 · 1 location(s) · Mansoura University · NCT06863194Ketoanalogue Supplementation for Muscle Protection in CKD 4 and 5 Patients With Moderately Low Protein Diet (KETO-PROT-A
Phase 3 · 1 location(s) · University Hospital, Clermont-Ferrand · NCT07374042Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD
NA · 1 location(s) · Yonsei University · NCT07524101Time-restricted Eating in Patients With Moderate Chronic Kidney Disease and Albuminuria
NA · 1 location(s) · de Seigneux Sophie · NCT06618859Safety and Efficacy of SC101 Via Perirenal Fat Injection for Resistant Hypertension in Patients With Moderate to Severe
Phase 1 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT07483372
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.